Immune Response to Sipuleucel-T in Prostate Cancer

Historically, chemotherapy has remained the most commonly utilized therapy in patients with metastatic cancers. In prostate cancer, chemotherapy has been reserved for patients whose metastatic disease becomes resistant to first line castration or androgen deprivation. While chemotherapy palliates, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Thara, Eddie, Dorff, Tanya B., Averia-Suboc, Monica, Luther, Michael, Reed, Mary E., Pinski, Jacek K., Quinn, David I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712699/
https://www.ncbi.nlm.nih.gov/pubmed/24213318
http://dx.doi.org/10.3390/cancers4040420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712699/
https://www.ncbi.nlm.nih.gov/pubmed/24213318
http://dx.doi.org/10.3390/cancers4040420

Ejemplares similares